Liming Xu

3.4k total citations
120 papers, 1.5k citations indexed

About

Liming Xu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Liming Xu has authored 120 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Liming Xu's work include Lung Cancer Research Studies (15 papers), Lymphoma Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (10 papers). Liming Xu is often cited by papers focused on Lung Cancer Research Studies (15 papers), Lymphoma Diagnosis and Treatment (14 papers) and Lung Cancer Treatments and Mutations (10 papers). Liming Xu collaborates with scholars based in China, United States and Canada. Liming Xu's co-authors include Mei Yang, Yanling Liu, Lingping Zhu, Zhiyong Yuan, Pingfang Yang, Cheng Pan, Yajing Yuan, Yanni Han, Ping Wang and Weidong Ke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Liming Xu

105 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liming Xu China 24 649 396 243 234 230 120 1.5k
Ming Cui China 24 788 1.2× 817 2.1× 346 1.4× 84 0.4× 133 0.6× 111 2.1k
Jill E. Kucab United Kingdom 18 913 1.4× 359 0.9× 124 0.5× 124 0.5× 57 0.2× 26 1.7k
Jianping Zhang China 26 712 1.1× 426 1.1× 299 1.2× 143 0.6× 84 0.4× 91 1.7k
Jia Song China 25 1.2k 1.8× 275 0.7× 215 0.9× 105 0.4× 92 0.4× 99 1.8k
Zhihua Gong China 21 529 0.8× 437 1.1× 347 1.4× 308 1.3× 149 0.6× 71 1.7k
Duk-Hwan Kim South Korea 26 1.3k 2.0× 426 1.1× 325 1.3× 202 0.9× 387 1.7× 64 2.1k
Xiaochen Zhou China 22 599 0.9× 95 0.2× 233 1.0× 397 1.7× 258 1.1× 74 1.4k
Haitao Liu China 21 647 1.0× 139 0.4× 364 1.5× 35 0.1× 136 0.6× 85 1.3k
Hongzhi Sun China 26 935 1.4× 258 0.7× 118 0.5× 92 0.4× 48 0.2× 71 1.7k
Qinghua Zeng China 23 1.5k 2.3× 541 1.4× 127 0.5× 230 1.0× 65 0.3× 63 2.4k

Countries citing papers authored by Liming Xu

Since Specialization
Citations

This map shows the geographic impact of Liming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Xu more than expected).

Fields of papers citing papers by Liming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Xu. The network helps show where Liming Xu may publish in the future.

Co-authorship network of co-authors of Liming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Xu. A scholar is included among the top collaborators of Liming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Xu. Liming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Mingjun, Liming Xu, Ming Zhao, et al.. (2025). Ionic liquid-based electrolytes for aqueous zinc metal batteries. 2. 100019–100019. 1 indexed citations
3.
Li, You, Liming Xu, Guangming Yang, et al.. (2025). SQSTM1/p62 Mediates the Effects of CPNE3 on the Epithelialmesenchymal Transition and Migration Inhibition of Lung Adenocarcinoma Cells. Current Medicinal Chemistry. 32(40). 9212–9223.
4.
Xu, Liming, et al.. (2024). Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders. Brain Research. 1830. 148821–148821. 2 indexed citations
6.
Xu, Liming, et al.. (2024). Diffuse large B‐cell lymphoma with BRAFV600E mutation mimicking thyroid carcinoma in fine‐needle aspiration: A diagnostic pitfall. SHILAP Revista de lepidopterología. 12(9). e9412–e9412.
7.
Yu, Yue, Ruizhi Liu, Boyang Xia, et al.. (2024). A survey on deep learning-based algorithms for the traveling salesman problem. Frontiers of Computer Science. 19(6). 2 indexed citations
8.
Cheng, Chingyun, Liming Xu, Hao Jing, et al.. (2024). The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation. Cancers. 16(19). 3249–3249. 6 indexed citations
10.
Li, Xiao, Jinpeng Li, Liming Xu, et al.. (2022). CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. Journal of Experimental & Clinical Cancer Research. 41(1). 149–149. 29 indexed citations
12.
Lin, Shuang, Rui Zhang, Lei Xu, et al.. (2020). LncRNA Hoxaas3 promotes lung fibroblast activation and fibrosis by targeting miR-450b-5p to regulate Runx1. Cell Death and Disease. 11(8). 706–706. 32 indexed citations
13.
Gong, Lin, et al.. (2019). Construction and clinical evaluation of a new customized bite block used in radiotherapy of head and neck cancer. Cancer/Radiothérapie. 23(2). 125–131. 17 indexed citations
14.
Xu, Liming, Duanmin Hu, Wen Tang, et al.. (2019). Adenomyoma of the distal common bile duct demonstrated by endoscopic ultrasound: A case report and review of the literature. World Journal of Clinical Cases. 7(21). 3615–3621. 3 indexed citations
15.
Li, Xiangpan, Huibo Zhang, Xuemei Jia, et al.. (2019). Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study. Translational Cancer Research. 8(4). 1074–1085. 5 indexed citations
16.
Xu, Liming, et al.. (2018). Effect of low-flow sevoflurane anesthesia on early postoperative renal function. Zhonghua mazuixue zazhi. 38(12). 1426–1429.
17.
Xu, Liming, Minglei Kang, Bo Jiang, Qingfeng Liu, & Ye‐Xiong Li. (2017). A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma. Medical dosimetry. 43(1). 91–99. 4 indexed citations
18.
Xu, Liming, Lujun Zhao, Xiuli Chen, et al.. (2015). Comparison of efficacy of different fractionation schedules in radiotherapy for extensive-stage small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 24(5). 488–492. 1 indexed citations
19.
Yang, Mei, Liming Xu, Yanling Liu, & Pingfang Yang. (2015). RNA-Seq Uncovers SNPs and Alternative Splicing Events in Asian Lotus (Nelumbo nucifera). PLoS ONE. 10(4). e0125702–e0125702. 22 indexed citations
20.
Yang, Mei, Yanni Han, Robert VanBuren, et al.. (2012). Genetic linkage maps for Asian and American lotus constructed using novel SSR markers derived from the genome of sequenced cultivar. BMC Genomics. 13(1). 653–653. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026